A 3D InSight into drug discovery with Tecan’s Infinite M200 PRO

A novel solution for analyzing 3D cell cultures, based onTecan's Infinite M200 PRO and InSphero's 3D InSight microtissue technology, ishelping to reduce the cost of early-phase drug development. Dr. Jens M. Kelm,co-founder and chief scientific officer of InSphero, explains: "Althoughclassical 2D cell culture techniques are still widely used throughout thepharmaceutical industry, their limitations are becoming increasingly apparent.The efficacy of a candidate drug depends on a number of factors, including thephysical and chemical environments invivo, drug penetration and clearance rates. 2D cell cultures do notaccurately reflect how all of these factors will affect drug behavior in vivo; 3D cell culturing techniquesoffer greater biological relevance for drug screening." 

Tecan

www.tecan.com